NVAX earnings: a negative outcome, -26.7%

On February 28, 2024, Novavax, Inc. reached its earnings. The result was a negative outcome, and the stock moved -26.7% in the window around the event. It had already run +26.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.